| Thomas K Takayama, MD | |
|
1135 116th Ave Ne, Suite 620, Bellevue, WA 98004-4623 | |
| (425) 454-8016 | |
| (425) 453-2827 |
| Full Name | Thomas K Takayama |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 39 Years |
| Location | 1135 116th Ave Ne, Bellevue, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720166184 | NPI | - | NPPES |
| 1017428 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | MD00026422 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Overlake Hospital Medical Center | Bellevue, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Overlake Medical Clinics Llc | 7012808827 | 350 |
News Archive
When the Trump administration in June issued rules making it easier for small employers to band together to buy health insurance, "we started looking immediately," recalled Scott Lyon, a top executive at the Small Business Association of Michigan.
Malignant neuroendocrine tumors (NETs) are relatively rare, notoriously difficult to treat, and associated with poor long-term survival. According to research presented at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging, an investigative blood test could predict how patients will respond to peptide receptor radionuclide therapy (PRRT) before they commit to a course of treatment.
The announcement by medicines watchdog the National Institute for Health and Care Excellence (NICE) that exercise should be recommended to people suffering from chronic pain, rather than prescribed painkillers, has been welcomed by rehabilitation science expert at Kingston University and St George's, University of London Professor Mike Hurley.
One of the challenges in evaluating the effectiveness of alcohol treatment is determining what constitutes a "good" outcome or meaningful improvement. While abstinence at the end of treatment is clearly a good outcome, a focus on abstinence ignores the benefits of patients reducing their drinking to less problematic levels so that they can function better and incur fewer social costs.
SARcode Corporation announced today that clinical data for their lead compound, SAR 1118, has been accepted for presentation during the upcoming Association for Research in Vision and Ophthalmology Annual Meeting being held May 1–May 5, 2011, in Fort Lauderdale, Florida.
› Verified 5 days ago
| Entity Name | Overlake Medical Clinics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801828421 PECOS PAC ID: 7012808827 Enrollment ID: O20040322001533 |
News Archive
When the Trump administration in June issued rules making it easier for small employers to band together to buy health insurance, "we started looking immediately," recalled Scott Lyon, a top executive at the Small Business Association of Michigan.
Malignant neuroendocrine tumors (NETs) are relatively rare, notoriously difficult to treat, and associated with poor long-term survival. According to research presented at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging, an investigative blood test could predict how patients will respond to peptide receptor radionuclide therapy (PRRT) before they commit to a course of treatment.
The announcement by medicines watchdog the National Institute for Health and Care Excellence (NICE) that exercise should be recommended to people suffering from chronic pain, rather than prescribed painkillers, has been welcomed by rehabilitation science expert at Kingston University and St George's, University of London Professor Mike Hurley.
One of the challenges in evaluating the effectiveness of alcohol treatment is determining what constitutes a "good" outcome or meaningful improvement. While abstinence at the end of treatment is clearly a good outcome, a focus on abstinence ignores the benefits of patients reducing their drinking to less problematic levels so that they can function better and incur fewer social costs.
SARcode Corporation announced today that clinical data for their lead compound, SAR 1118, has been accepted for presentation during the upcoming Association for Research in Vision and Ophthalmology Annual Meeting being held May 1–May 5, 2011, in Fort Lauderdale, Florida.
› Verified 5 days ago
| Entity Name | Washington Urology Associates, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962719302 PECOS PAC ID: 6103005723 Enrollment ID: O20110127000710 |
News Archive
When the Trump administration in June issued rules making it easier for small employers to band together to buy health insurance, "we started looking immediately," recalled Scott Lyon, a top executive at the Small Business Association of Michigan.
Malignant neuroendocrine tumors (NETs) are relatively rare, notoriously difficult to treat, and associated with poor long-term survival. According to research presented at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging, an investigative blood test could predict how patients will respond to peptide receptor radionuclide therapy (PRRT) before they commit to a course of treatment.
The announcement by medicines watchdog the National Institute for Health and Care Excellence (NICE) that exercise should be recommended to people suffering from chronic pain, rather than prescribed painkillers, has been welcomed by rehabilitation science expert at Kingston University and St George's, University of London Professor Mike Hurley.
One of the challenges in evaluating the effectiveness of alcohol treatment is determining what constitutes a "good" outcome or meaningful improvement. While abstinence at the end of treatment is clearly a good outcome, a focus on abstinence ignores the benefits of patients reducing their drinking to less problematic levels so that they can function better and incur fewer social costs.
SARcode Corporation announced today that clinical data for their lead compound, SAR 1118, has been accepted for presentation during the upcoming Association for Research in Vision and Ophthalmology Annual Meeting being held May 1–May 5, 2011, in Fort Lauderdale, Florida.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas K Takayama, MD 1135 116th Ave Ne, Suite 620, Bellevue, WA 98004-4623 Ph: (425) 454-8016 | Thomas K Takayama, MD 1135 116th Ave Ne, Suite 620, Bellevue, WA 98004-4623 Ph: (425) 454-8016 |
News Archive
When the Trump administration in June issued rules making it easier for small employers to band together to buy health insurance, "we started looking immediately," recalled Scott Lyon, a top executive at the Small Business Association of Michigan.
Malignant neuroendocrine tumors (NETs) are relatively rare, notoriously difficult to treat, and associated with poor long-term survival. According to research presented at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging, an investigative blood test could predict how patients will respond to peptide receptor radionuclide therapy (PRRT) before they commit to a course of treatment.
The announcement by medicines watchdog the National Institute for Health and Care Excellence (NICE) that exercise should be recommended to people suffering from chronic pain, rather than prescribed painkillers, has been welcomed by rehabilitation science expert at Kingston University and St George's, University of London Professor Mike Hurley.
One of the challenges in evaluating the effectiveness of alcohol treatment is determining what constitutes a "good" outcome or meaningful improvement. While abstinence at the end of treatment is clearly a good outcome, a focus on abstinence ignores the benefits of patients reducing their drinking to less problematic levels so that they can function better and incur fewer social costs.
SARcode Corporation announced today that clinical data for their lead compound, SAR 1118, has been accepted for presentation during the upcoming Association for Research in Vision and Ophthalmology Annual Meeting being held May 1–May 5, 2011, in Fort Lauderdale, Florida.
› Verified 5 days ago
Robert M Weissman, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1135 Ne 116th Ave., Suite 620, Bellevue, WA 98004 Phone: 425-454-8016 Fax: 425-453-2827 | |
Wendy Siu, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3000 | |
Dr. Martin J Wall, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1135 116th Ave Ne, Suite 620, Bellevue, WA 98004 Phone: 425-454-8016 Fax: 425-453-2827 | |
Richard Stuart Pelman, MD Urology Medicare: Medicare Enrolled Practice Location: 3100 Northup Way, Bellevue, WA 98004 Phone: 425-646-7777 | |
Dr. Khanh Ngoc Pham, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1135 116th Ave Ne Ste 620, Bellevue, WA 98004 Phone: 425-454-8016 Fax: 425-453-2827 | |
Mrs. Elizabeth Anne Miller, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1135 Ne 116th Ave, Suite 620, Bellevue, WA 98004 Phone: 425-454-8016 Fax: 425-453-2827 | |
Susan Paulette Kupferman, Urology Medicare: Accepting Medicare Assignments Practice Location: 1600 116th Ave Ne, Suite #104, Bellevue, WA 98004 Phone: 425-454-0345 |